about
Removing the bottleneck in whole genome sequencing of Mycobacterium tuberculosis for rapid drug resistance analysis: a call to actionMycobacterium celeriflavum sp. nov., a rapidly growing scotochromogenic bacterium isolated from clinical specimens.PhyResSE: a Web Tool Delineating Mycobacterium tuberculosis Antibiotic Resistance and Lineage from Whole-Genome Sequencing Data.Mycobacterium angelicum sp. nov., a non-chromogenic, slow-growing species isolated from fish and related to Mycobacterium szulgai.Mycobacterium alsense sp. nov., a scotochromogenic slow grower isolated from clinical respiratory specimens.Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter studyDiagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter StudyDelamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system.Use of WGS in Mycobacterium tuberculosis routine diagnosis.Best approaches to drug-resistance surveillance at the country level.Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project.Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment.Consensus numbering system for the rifampicin resistance-associated rpoB gene mutations in pathogenic mycobacteria.GenoType MTBDRsl performance on clinical samples with diverse genetic background.Genotypic and phenotypic M. tuberculosis resistance: guiding clinicians to prescribe the correct regimens.Countrywide implementation of whole genome sequencing: an opportunity to improve tuberculosis management, surveillance and contact tracing in low incidence countries.Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey.Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study.Low prevalence of fluoroquinolone resistance among patients with tuberculosis in the Philippines: results of a national survey.Bedaquiline Phenotypic and Genotypic Susceptibility Testing, Work in Progress!Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA SequencingRole of Disputed Mutations in the Gene in Interpretation of Automated Liquid MGIT Culture Results for Rifampin Susceptibility Testing of Mycobacterium tuberculosisWhole genome sequencing of Mycobacterium tuberculosisExportation of MDR TB to Europe from Setting with Actively Transmitted Persistent Strains in PeruWhole-Genome Sequencing of Drug-Resistant Mycobacterium tuberculosis Strains, Tunisia, 2012-2016Is sequencing better than phenotypic tests for the detection of pyrazinamide resistance?Screening of inmates transferred to Spain reveals a Peruvian prison as a reservoir of persistent Mycobacterium tuberculosis MDR strains and mixed infectionsFluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populationsPrevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional dataWhole genome sequencing of Mycobacterium tuberculosis: current standards and open issuesLack of association of novel mutation Asp397Gly in aftB gene with ethambutol resistance in clinical isolates of Mycobacterium tuberculosis
P50
Q28070235-130620E4-2724-41A0-9737-AE067BF3BA3EQ30868869-F0CFF6B9-835F-492B-99AB-31DD1FF1F74FQ30927278-8113C7C7-190B-4238-82A0-53B50AB933D9Q30999408-18F3C5C0-D1B5-4B66-A431-647D3DDBF1F6Q31019154-5A46B704-1D57-4B7E-84F6-6999FB0A8E6DQ34420149-7113E047-81C3-4815-AEDF-A437427D064AQ35693044-287327C3-9FA0-4E0D-977B-8969CCC534FBQ35989196-037B6639-357F-41FD-AEF7-023B4F609CB5Q36237531-83C128A9-8FA6-4E32-A006-1BB9C18EEB00Q36237546-6250B046-B043-46C3-AC3C-C776B51DDB9AQ37270722-2CF8012D-E977-4945-88F1-4A98EBC9D0D3Q38739933-D2E08EC3-5829-40B0-A31D-5A4CBF353EC4Q38875204-3BAA6B9E-9FE5-4D0C-A960-5EDF09623E18Q43757490-4DDC0CE5-8971-48C2-9380-1E77D48B42EDQ48334866-4E48C08F-B8F3-4FA6-856D-9534254AC431Q52591135-9693A32E-4E3D-45EB-81DF-6171F4BC2C6AQ52673474-087EC820-8968-413D-ADF5-3A829347CAE2Q53698791-D9F158A4-C771-4914-8FEE-5BC164791176Q53705345-B5102F64-5A37-4645-8E6E-267F76418C45Q54249699-0DFE899D-D209-47F2-AC1C-4971081D215CQ57069356-72114A57-4077-4151-B8DB-17848F419210Q58865294-CFE12A20-E776-4D48-96AB-05411D44174CQ58880864-D3FEC69A-7F6A-489F-83D1-F15518DD2DD6Q64076136-E7BB979F-1CDD-44EB-8891-DD5F12A97A0DQ64076204-0F01287B-2AFE-43FA-95BE-548BE71CBF34Q88970245-6B51AD6A-9FAE-4C8D-A599-E6EF964BCBB8Q89747692-07E974F7-994B-48DD-9F86-B2587C22C2B9Q92602901-D51F92A7-2303-42C8-9D4F-6D4F06C26A5AQ92802220-F50D41C7-850F-417C-A9AE-669772CD6BC9Q92826914-29DB28A7-C21A-42AE-9D92-18F7B9CD544CQ92857472-AAFF93EA-EA68-492C-85D8-DEC44C842BBF
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Andrea M. Cabibbe
@ast
Andrea M. Cabibbe
@en
Andrea M. Cabibbe
@es
Andrea M. Cabibbe
@nl
type
label
Andrea M. Cabibbe
@ast
Andrea M. Cabibbe
@en
Andrea M. Cabibbe
@es
Andrea M. Cabibbe
@nl
altLabel
Andrea Maurizio Cabibbe
@en
prefLabel
Andrea M. Cabibbe
@ast
Andrea M. Cabibbe
@en
Andrea M. Cabibbe
@es
Andrea M. Cabibbe
@nl
P106
P1153
55352619300
P21
P2798
P31
P496
0000-0001-9727-6465